C. David Mazer

1990–2025 年に発表

123
論文数
23,221
被引用数
69
h 指数
116
i10 指数

被引用数

C. David Mazer の年別被引用数1983 年: 被引用 1 件1991 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 1 件1997 年: 被引用 8 件1998 年: 被引用 2 件1999 年: 被引用 11 件2000 年: 被引用 19 件2001 年: 被引用 11 件2002 年: 被引用 15 件2003 年: 被引用 24 件2004 年: 被引用 33 件2005 年: 被引用 54 件2006 年: 被引用 38 件2007 年: 被引用 37 件2008 年: 被引用 77 件2009 年: 被引用 96 件2010 年: 被引用 99 件2011 年: 被引用 126 件2012 年: 被引用 160 件2013 年: 被引用 199 件2014 年: 被引用 146 件2015 年: 被引用 160 件2016 年: 被引用 175 件2017 年: 被引用 133 件2018 年: 被引用 149 件2019 年: 被引用 635 件2020 年: 被引用 734 件2021 年: 被引用 794 件2022 年: 被引用 631 件2023 年: 被引用 419 件2024 年: 被引用 721 件2025 年: 被引用 350 件2026 年: 被引用 9 件1984〜1990 年は被引用が無いため表示していません1992〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,021 件、この内訳の 21.7%イギリス: 引用元論文 871 件、この内訳の 9.3%カナダ: 引用元論文 809 件、この内訳の 8.7%ドイツ: 引用元論文 494 件、この内訳の 5.3%イタリア: 引用元論文 483 件、この内訳の 5.2%中国: 引用元論文 481 件、この内訳の 5.2%オーストラリア: 引用元論文 400 件、この内訳の 4.3%フランス: 引用元論文 361 件、この内訳の 3.9%オランダ: 引用元論文 283 件、この内訳の 3%スペイン: 引用元論文 228 件、この内訳の 2.5%スイス: 引用元論文 205 件、この内訳の 2.2%ベルギー: 引用元論文 200 件、この内訳の 2.1%
0%21.7%その他 26.6%

分野

  • Medicine89.6%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Nursing1.5%
  • Engineering1.4%
  • Health Professions1%
  • Neuroscience0.6%
  • その他2%

トピック

  • Intensive Care Unit Cognitive Disorders7.1%
  • Blood transfusion and management4.4%
  • Respiratory Support and Mechanisms4.4%
  • Trauma, Hemostasis, Coagulopathy, Resuscitation4.4%
  • Sepsis Diagnosis and Treatment4%
  • Diabetes Treatment and Management4%
  • その他71.7%

共著者

全論文

検索で開く
  1. Functional Disability 5 Years after Acute Respiratory Distress Syndrome

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 2,838

  2. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stuart J. Connolly - New England Journal of Medicine 2021 被引用: 691

  3. One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2003 被引用: 2,330

  4. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 578

  5. Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nadine Shehata - New England Journal of Medicine 2017 被引用: 762

  6. Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    著者: , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 357

  7. A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lee A. Fleisher, Mark D. Neuman, David Story, Russell L. Gruen, Sohail Bampoe, Lisbeth Evered, David A. Scott, Brendan Silbert, Diederik van Dijk, Cor J. Kalkman, Matthew T.V. Chan, Hilary P. Grocott, Roderic G. Eckenhoff, Lars S. Rasmussen, Lars Eriksson, Scott Beattie, Duminda N. Wijeysundera, Giovanni Landoni, Kate Leslie, Bruce Biccard, Simon Howell, Peter Nägele, Toby Richards, André Lamy, Marcelo Gabreu, Andrew C. Klein, Tomás Corcoran, D. James Cooper, Jan M. Dieleman, E Diouf, David R. McIlroy, Rinaldo Bellomo, Andrew Shaw, John R. Prowle, Keyvan Karkouti, J. Billings, C. David Mazer, Mohindas Jayarajah, Michael K. Murphy, Justyna Bartoszko, J. Robert Sneyd, Shaine A. Morris, Ronald B. George, Ramani Moonesinghe, Mark Shulman, Meghan B. Lane‐Fall, Ulrica Nilsson, Nathalie Stevenson, Wilton A. van Klei, Luca Cabrini, Timothy E. Miller, Nathan L. Pace, S. Jackson, Donal J. Buggy, Timothy G. Short, Bernhard Riedel, V. Gottumukkala, Bilal Alkhaffaf, Mark Johnson - British Journal of Anaesthesia 2018 被引用: 415

  8. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Harry Sivakumar, A. Murmane, K. Kenchington, Y. Kirabiyik, Usha Gurunathan, C. Stonell, K. Brunello, Katherine T. Steele, Oystein Tronstad, P. Masel, Annette Dent, Emma Smith, A Bodger, M. Abolfathi, P Sivalingam, Adrian Hall, Thomas Painter, S. Macklin, Adrian D. Elliott, Anna María Claverol Carrera, N Terblanche, S. Pitt, J. Samuel, Chris Wilde, Kate Leslie, Andrew MacCormick, David E. Bramley, Anne Marie Southcott, J. C. Boileau Grant, H. Taylor, Samantha Bates, Miriam Towns, Anna Tippett, Fiona Marshall, C. David Mazer, J. Kunasingam, Anmol Yagnik, C. Crescini, S. Yagnik, Colin J. L. McCartney, Priya Somascanthan, Stephen Choi, K. Flores, Shelly Au, W. Scott Beattie, Keyvan Karkouti, Hance Clarke, Angela Jerath, Stuart A. McCluskey, Marcin Wąsowicz, Lauren Day, Janneth Pazmino‐Canizares, Paul Oh, Rene Belliard, Leanna Lee, Karen Dobson, Vincent Chan, Richard Brull, Noam Ami, Matthew B. Stanbrook, K. Hagen, Douglas Campbell, Timothy G. Short, J. Van Der Westhuizen, Kushlin Higgie, Helen Lindsay, R. Jang, Chris Ho Ming Wong, Davina McAllister, Marlynn Ali ほか 75 名 - The Lancet 2018 被引用: 480

  9. Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study

    著者: , , , , , , , , , , , , , - Circulation 2021 被引用: 92

  10. Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials

    著者: , , , , , , , , , , , - Diabetes Obesity and Metabolism 2020 被引用: 93

  11. Effect of perioperative benzodiazepine use on intraoperative awareness and postoperative delirium: a systematic review and meta-analysis of randomised controlled trials and observational studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arastoo Mokhtari, Eric Jacobsohn, Jessica Spence - British Journal of Anaesthesia 2023 被引用: 66

  12. SGLT2 Inhibitors and Cardiac Remodelling: A Systematic Review and Meta-Analysis of Randomized Cardiac Magnetic Resonance Imaging Trials

    著者: , , , , , , - ESC Heart Failure 2021 被引用: 88

  13. Aldosterone and aldosterone synthase inhibitors in cardiorenal disease

    著者: , , , , , , , , , , , - American Journal of Physiology-Heart and Circulatory Physiology 2023 被引用: 54

  14. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

    著者: , , , , , , , , , , , , , - Biochemical and Biophysical Research Communications 2020 被引用: 140

  15. Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease

    著者: , , , , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2021 被引用: 94

  16. 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

    著者: , , , , , , , , , , , , , , , , , , - The Annals of Thoracic Surgery 2011 被引用: 1,311

  17. Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , H. Sivakumar, A. Murmane, K. Kenchington, Y. Kirabiyik, Usha Gurunathan, C. Stonell, K. Brunello, Katherine T. Steele, Oystein Tronstad, P. Masel, Annette Dent, Emma Smith, A Bodger, M. Abolfathi, P Sivalingam, Andrew P. Hall, Thomas Painter, S. Macklin, Adrian D. Elliott, Anna María Claverol Carrera, N Terblanche, Susan C. Pitt, Jason M. Samuels, C. Wilde, Kate Leslie, Andrew MacCormick, David E. Bramley, Anne Marie Southcott, Jonathan Grant, H. Taylor, Samantha Bates, Michael Towns, Anna Tippett, Fray F. Marshall, C. David Mazer, J. Kunasingam, Anmol Yagnik, C. Crescini, S. Yagnik, Colin J. L. McCartney, Stephen Choi, Priya Somascanthan, K. Flores, Duminda N. Wijeysundera, W. Scott Beattie, Keyvan Karkouti, Hance Clarke, Angela Jerath, Stuart A. McCluskey, Marcin Wąsowicz, J.T. Granton, Lauren Day, Janneth Pazmino‐Canizares, Paul Oh, R. Belliard, L. Lee, K. Dobson, Vincent Chan, Richard Brull, Noam Ami, Matthew B. Stanbrook, K. Hagen, Douglas Campbell, Timothy G. Short, J. Van Der Westhuizen, Kushlin Higgie, Helen Lindsay, R. Jang, Chris Ho Ming Wong, Davina McAllister ほか 117 名 - British Journal of Anaesthesia 2019 被引用: 164

  18. Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease

    著者: , , , , , , , - Diabetes Obesity and Metabolism 2022 被引用: 55

  19. Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial

    著者: , , , , , , - Diabetologia 2018 被引用: 125

  20. SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus

    著者: , , , , , , , , , , , , , , , , - Cell Metabolism 2019 被引用: 108

  21. Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mike Grocott, Tim Cook, Lee A. Fleisher, Mark D. Neuman, David Story, Russell L. Gruen, Sam Bampoe, Lisbeth Evered, David A. Scott, Brendan Silbert, Diederik van Dijk, Cor J. Kalkman, Matthew T.V. Chan, Hilary P. Grocott, Guy Haller, Rod Eckenhoff, Lars S. Rasmussen, Lars Eriksson, Scott Beattie, Duminda N. Wijeysundera, Lee A. Fleisher, Giovanni Landoni, Kate Leslie, Bruce Biccard, Simon Howell, Hilary P. Grocott, Peter Nägele, Toby Richards, André Lamy, Manoj M. Lalu, Richard J. Bartlett, Robert McMonnies, Jakob V. E. Gerstl, Mohammad Jay, David Kishlyansky, Matthew Machina, Matthew Bobcock, Simon Feng, Rupert M. Pearse, Monty Mythen, Jaume Canet, Ann Merete Møller, Tony Gin, Marcus J. Schultz, Paolo Pelosi, Marcelo Gabreu, Emmanuel Futier, Ben Creagh‐Brown, Tom Abbott, Monty Mythen, Cor J. Kalkman, Andy Klein, Tomás Corcoran, D. James Cooper, Stefan Dieleman, E Diouf, David R. McIlroy, Rinaldo Bellomo, Andrew Shaw, John R. Prowle, Keyvan Karkouti, J. Billings, Duminda N. Wijeysundera, Andy Klein, Toby Richards, C. David Mazer, Paul S. Myles, Mohindas Jayarajah, Keyvan Karkouti, Michael K. Murphy ほか 40 名 - British Journal of Anaesthesia 2020 被引用: 112

  22. Two-Year Outcomes, Health Care Use, and Costs of Survivors of Acute Respiratory Distress Syndrome

    著者: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2006 被引用: 474

  23. Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Jüni, Nadine Shehata - New England Journal of Medicine 2018 被引用: 243

  24. A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 被引用: 1,147